17-32494815-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_015194.3(MYO1D):āc.2965C>Gā(p.Gln989Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,613,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_015194.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO1D | NM_015194.3 | c.2965C>G | p.Gln989Glu | missense_variant | 22/22 | ENST00000318217.10 | |
MYO1D | NM_001411088.1 | c.2701C>G | p.Gln901Glu | missense_variant | 23/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO1D | ENST00000318217.10 | c.2965C>G | p.Gln989Glu | missense_variant | 22/22 | 1 | NM_015194.3 | P1 | |
MYO1D | ENST00000394649.8 | c.2701C>G | p.Gln901Glu | missense_variant | 24/24 | 5 | |||
MYO1D | ENST00000577352.5 | n.912C>G | non_coding_transcript_exon_variant | 6/6 | 2 | ||||
MYO1D | ENST00000577576.1 | n.219C>G | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000220 AC: 55AN: 249486Hom.: 0 AF XY: 0.000237 AC XY: 32AN XY: 135136
GnomAD4 exome AF: 0.000135 AC: 198AN: 1461326Hom.: 0 Cov.: 31 AF XY: 0.000155 AC XY: 113AN XY: 726976
GnomAD4 genome AF: 0.000204 AC: 31AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74474
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at